1 |
Coates, P., S. Vyakrnam, E.A. Eady, C.E. Jones, J.H. Cove, and W.J. Cunliffe. 2002. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br. J. Dermatol. 146, 840-848
DOI
ScienceOn
|
2 |
Lee, J., E. Jung, J. Park, K. Jung, S. Lee, S. Hong, J. Park, E. Park, J. Kim, S. Park, and D. Park. 2005. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF- B activation signaling. Planta. Med. 71, 338-343
DOI
ScienceOn
|
3 |
Lin, R.D., Y.P. Chin, and M.H. Lee. 2005. Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum -lactamase (ESBL)-producing Klebsiella pneumoniae. Phytother. Res. 19, 612-617
DOI
ScienceOn
|
4 |
Vowels, B.R., S. Yang, and L.L. Leyden. 1995. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: Implications for chronic inflammatory acne. Infect. Immun. 63, 3158-3165
PUBMED
|
5 |
Arima, H., H. Ashida, and G. Danno. 2002. Rutin-enhanced antibacterial activities of flavonoids against Bacillus cereus and Salmonella enteritidis. Biosci. Biotechnol. Biochem. 66, 1009-1014
DOI
ScienceOn
|
6 |
Eady, E.A. and E. Ingham. 1994. Propionibacterium acnes-friend of foe? Rev. Med. Microbiol. 5, 163-173
DOI
ScienceOn
|
7 |
Bojar, R.A. and K.T. Holland. 2004. Acne and Propionibacterium acnes. Clin. Dermatol. 22, 375-379
DOI
ScienceOn
|
8 |
Viluksela, M., P.J. Vainio, and R.K. Tuominen. 1996. Cytotoxicity of macrolide antibiotics in a cultured human liver cell line. J. Antimicrob. Chemother. 38, 465-473
DOI
ScienceOn
|
9 |
Wang, L., Y.C. Tu, T.W. Lian, J.T. Hung, J.H. Yen, and M.J. Wu. 2006. Distinctive antioxidant and anti-inflammatory effects of flavonols. J. Agric. Food Chem. 54, 9798-9804
DOI
ScienceOn
|
10 |
Wu, Y.L., E.M. Scott, A.L.W. Po, and V.N. Tariq. 1999. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 44, 389-392
DOI
|
11 |
Liang, Y.C., Y.T. Huang, S.H. Tsai, S.Y. Shiau, C.F. Chen, and J.K. Lin. 1999. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20, 1945-1952
DOI
ScienceOn
|
12 |
Sobieszczyk, M.E., E.Y. Furuya, C.M. Hay, P. Pancholi, P. Della- Latta, S.M. Hammer, and C.J. Kubin. 2004. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. J. Antimicrob. Chemother. 54, 566-569
DOI
ScienceOn
|
13 |
Eady, E.A., M. Gloor, and J.J. Leyden. 2003. Propionibacterium acnes resistance: A world problem. Dermatology 206, 54-56
DOI
ScienceOn
|
14 |
Kang, S.C. and Y. Moon. 1992. Isolation and antimicrobial activity of a naphthoquinone from Impatiens balsamina. Saengyak Hakhoechi 23, 240-247
과학기술학회마을
|
15 |
Bialecka, A., M. Mak, R. Biedron, M. Bobek, A. Kasprowicz, and J. Marcinkiewicz. 2005. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne. Arch. Immunol. Ther. Exp. 53, 79-85
PUBMED
|
16 |
Gould, I.M. and K. Milne. 1997. In vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin. J. Antimicrob. Chemother. 39, 53-61
|
17 |
Chivot, M. 2005. Retinoid therapy for acne. Am. J. Clin. Dermatol. 6, 13-19
DOI
ScienceOn
|
18 |
National Committee for Clinical Laboratory Standards. 1997. Methods for antimicrobial susceptibility testing of anaerobic bacteria: Tentative Standard M11-A4. National Committee for Clinical Laboratory Standards, Villanova, PA, USA
|
19 |
Jung, H.J., K.S. Choi, and D.G. Lee. 2005. Synergistic killing effect of synthetic peptide P20 and cefotaxime on methicillin-resistant nosocomial isolates of Staphylococcus aureus. J. Microbiol. Biotechnol. 15, 1039-1046
과학기술학회마을
|
20 |
Krautheim, A. and H.P.M. Gollnick. 2004. Acne: Topical treatment. Clin. Dermatol. 22, 398-407
DOI
ScienceOn
|
21 |
Lim, Y.H., I.H. Kim, J.J. Seo, and J.K. Kim. 2006. Tyrosinase inhibitor from the flowers of Impatiens balsamina. J. Microbiol. Biotechnol. 16, 1977-1983
과학기술학회마을
|
22 |
Meltz, M.L. and J.T. MacGregor. 1981. Activity of the plant flavonol quercetin in the mouse lymphoma L5178Y TK+/- mutation, DNA single-strand break, and Balb/c 3T3 chemical transformation assays. Mutat. Res. 88, 317-324
DOI
ScienceOn
|
23 |
Oprica, C. and C.E. Nord. 2005. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin. Microbiol. Infect. 11, 204-213
DOI
ScienceOn
|
24 |
Sung, W.S., H.J. Jung, I.S. Lee, H.S. Kim, and D.G. Lee. 2006. Antimicrobial effect of furaneol against human pathogenic bacteria and fungi. J. Microbiol. Biotechnol. 16, 349-354
과학기술학회마을
|
25 |
Yang, X., D.K. Summerhurst, S.F. Koval, C. Ficker, M.L. Smith, and M.A. Bernards. 2001. Isolation of an antimicrobial compound from Impatiens balsamina L. using bioassay-guided fraction. Phytother. Res. 15, 676-680
DOI
ScienceOn
|
26 |
Pillai, S.K., R.C. Moellering, and G.M. Eliopoulos. 2005. Antimicrobial combinations, p. 365-440. In V. Lorian (ed.), Antibiotics in Laboratory Medicine. Lippincott Williams & Wilkins, PA, USA
|
27 |
Ross, J.I., A.M. Snelling, E. Carnegie, P. Coates, W.J. Cunliffe, V. Bettoli, G. Tosti, A. Katsambas, J.I.G. Pulgar, O. Rollman, L. Török, E.A. Eady, and J.H. Cove. 2003. Antibiotic-resistant acne: lessons from Europe. Br. J. Dermatol. 148, 467-478
DOI
ScienceOn
|
28 |
Shannon, B.A., K.L. Garrett, and R.J. Cohen. 2006. Links between Propionibacterium acnes and prostate cancer. Future Oncol. 2, 225-232
DOI
ScienceOn
|
29 |
Mayer, I. and E. Nagy. 1999. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.. J. Antimicrob. Chemother. 43, 651-657
DOI
ScienceOn
|